{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:38:41Z","timestamp":1762864721468},"reference-count":19,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Recently, the Centers for Disease Control and Prevention reported an accurate, sensitive, specific, reproducible, and quantitative enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G (IgG) antibodies to\n            <jats:italic>Bacillus anthracis<\/jats:italic>\n            protective antigen (PA) in human serum (C. P. Quinn, V. A. Semenova, C. M. Elie et al., Emerg. Infect. Dis. 8:1103-1110, 2002). The ELISA had a minimum detectable concentration (MDC) of 0.06 \u03bcg\/ml, which, when dilution adjusted, yielded a whole-serum MDC of 3.0 \u03bcg of anti-PA IgG per ml. The reliable detection limit (RDL) was 0.09 \u03bcg\/ml, while the dynamic range was 0.06 to 1.7 \u03bcg\/ml. The diagnostic sensitivity of the assay was 97.6% and the diagnostic specificity was 94.2% for clinically verified cases of anthrax. A competitive inhibition anti-PA IgG ELISA was also developed to enhance the diagnostic specificity to 100%. We report a newly developed fluorescence covalent microbead immunosorbent assay (FCMIA) for\n            <jats:italic>B. anthracis<\/jats:italic>\n            PA which was Luminex xMap technology. The FCMIA MDC was 0.006 \u03bcg of anti-PA IgG per ml, the RDL was 0.016 \u03bcg\/ml, and the whole-serum equivalent MDC was 1.5 \u03bcg\/ml. The dynamic range was 0.006 to 6.8 \u03bcg\/ml. Using this system, we analyzed 20 serum samples for anti-PA IgG and compared our results to those measured by ELISA in a double-masked analysis. The two methods had a high positive correlation (\n            <jats:italic>r<\/jats:italic>\n            <jats:sup>2<\/jats:sup>\n            = 0.852;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001). The FCMIA appears to have benefits over the ELISA for the measurement of anti-PA IgG, including greater sensitivity and speed, enhanced dynamic range and reagent stability, the use of smaller sample volumes, and the ability to be multiplexed (measurement of more than one analyte simultaneously), as evidenced by the multiplexed measurement in the present report of anti-PA and anti-lethal factor IgG in serum from a confirmed clinical anthrax infection.\n          <\/jats:p>","DOI":"10.1128\/cdli.11.1.50-55.2004","type":"journal-article","created":{"date-parts":[[2004,1,11]],"date-time":"2004-01-11T00:18:20Z","timestamp":1073780300000},"page":"50-55","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":44,"title":["Comparison of a Multiplexed Fluorescent Covalent Microsphere Immunoassay and an Enzyme-Linked Immunosorbent Assay for Measurement of Human Immunoglobulin G Antibodies to Anthrax Toxins"],"prefix":"10.1128","volume":"11","author":[{"given":"Raymond E.","family":"Biagini","sequence":"first","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Sammons","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome P.","family":"Smith","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A. F.","family":"Striley","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Semenova","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelen","family":"Steward-Clark","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Stamey","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison E.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Snawder","sequence":"additional","affiliation":[{"name":"Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health, Cincinnati, Ohio"},{"name":"Microbial Pathogenesis and Immune Response Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-5193(87)80228-X","volume":"126","year":"1987","unstructured":"Bardsley, W. G., and P. B. McGinlay. 1987. The use of non-linear regression analysis and the F test for model discrimination with dose-response curves and ligand binding data. J. Theor. Biol.126:183-201.","journal-title":"J. Theor. Biol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s001280278","volume":"68","year":"2002","unstructured":"Biagini, R. E., D. M. Murphy, D. L. Sammons, J. P. Smith, C. A. Striley, and B. A. MacKenzie. 2002. Development of multiplexed fluorescence microbead covalent assays (FMCAs) for pesticide biomonitoring. Bull. Environ. Contam. Toxicol.68:470-477.","journal-title":"Bull. Environ. Contam. Toxicol."},{"key":"e_1_3_2_4_2","first-page":"744","volume":"10","year":"2003","unstructured":"Biagini, R. E., S. A. Schlottmann, D. L. Sammons, J. P. Smith, J. C. Snawder, C. A. Striley, B. A. MacKenzie, and D. N. Weissman. 2003. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin. Diagn. Lab. Immunol.10:744-750.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.1.133-139.2003"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","volume":"5","year":"1990","unstructured":"Hornung, R., and L. Reed. 1990. Estimate of average concentration in the presence of non-detectable values. Appl. Occup. Environ. Hyg.5:46-51.","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.1.1.78-82.1994"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.20506\/rst.17.2.1119","volume":"17","year":"1998","unstructured":"Jacobson, R. H. 1998. Validation of serological assays for diagnosis of infectious diseases. Rev. Sci. Tech.17:469-526.","journal-title":"Rev. Sci. Tech."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.20.3.357-361.1984"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0076-6879(91)95162-D","volume":"195","year":"1991","unstructured":"Leppla, S. 1991. Purification and characterization of adenyl cyclase from Bacillus anthracis.Methods Enzymol.195:153-168.","journal-title":"Methods Enzymol."},{"key":"e_1_3_2_11_2","unstructured":"Nix B. and D. Wild. 2001. Calibration curve-fitting p. 198-210. In D. Wild (ed.) The immunoassay handbook. Nature Publishing Group New York N.Y."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-7439(93)80008-6","volume":"20","year":"1993","unstructured":"O'Connell, M., B. Belanger, and P. Haaland. 1993. Calibration and assay development using the four-parameter logistic model. Chemometrics Intell. Lab. Systems20:97-114.","journal-title":"Chemometrics Intell. Lab. Systems"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/prep.2000.1208","volume":"18","year":"2000","unstructured":"Park, S., and S. Leppla. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expression Purif.18:293-302.","journal-title":"Protein Expression Purif."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1309\/LMCH-C4Q2-VFL9-3T1A"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.7.1439-1446.1991"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","volume":"8","year":"2002","unstructured":"Quinn, C. P., V. A. Semenova, C. M. Elie, S. Romero-Steiner, C. Greene, H. Li, K. Stamey, E. Steward-Clark, D. S. Schmidt, E. Mothershed, J. Pruckler, S. Schwartz, R. F. Benson, L. O. Helsel, P. F. Holder, S. E. Johnson, M. Kellum, T. Messmer, W. L. Thacker, L. Besser, B. D. Plikaytis, T. H. Taylor, Jr., A. E. Freeman, K. J. Wallace, P. Dull, J. Sejvar, E. Bruce, R. Moreno, A. Schuchat, J. R. Lingappa, S. K. Martin, J. Walls, M. Bronsdon, G. M. Carlone, M. Bajani-Ari, D. A. Ashford, D. S. Stephens, and B. A. Perkins. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis.8:1103-1110.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4269\/ajtmh.1988.39.575","volume":"39","year":"1988","unstructured":"Sirisanthana, T., K. E. Nelson, J. W. Ezzell, and T. G. Abshire. 1988. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. Am. J. Trop. Med. Hyg.39:575-581.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_18_2","first-page":"293","volume":"177","year":"1988","unstructured":"Turnbull, P. C., S. H. Leppla, M. G. Broster, C. P. Quinn, and J. Melling. 1988. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol. Immunol.177:293-303.","journal-title":"Med. Microbiol. Immunol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-1759(00)00238-6","volume":"243","year":"2000","unstructured":"Vignali, D. A. 2000. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods243:243-255.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.jom.0000058345.05741.6b","volume":"45","year":"2003","unstructured":"Wasserman, G. M., J. D. Grabenstein, P. R. Pittman, M. V. Rubertone, P. P. Gibbs, L. Z. Wang, and L. G. Golder. 2003. Analysis of adverse events after anthrax immunization in US Army medical personnel. J. Occup. Environ. Med.45:222-233.","journal-title":"J. Occup. Environ. Med."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.1.50-55.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.11.1.50-55.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:34:05Z","timestamp":1627590845000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.11.1.50-55.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1128\/CDLI.11.1.50-55.2004"],"URL":"https:\/\/doi.org\/10.1128\/cdli.11.1.50-55.2004","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"2003-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-10-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}